Nitrophenols
3,5-Dinitrosalicylaldehyde, 98%
CAS: 2460-59-5 Molecular Formula: C7H3N2O6 Molecular Weight (g/mol): 211.11 MDL Number: MFCD00007103 InChI Key: FLJXIBHYDIMYRS-UHFFFAOYSA-M PubChem CID: 75571 IUPAC Name: 2-formyl-4,6-dinitrobenzen-1-olate SMILES: [O-]C1=C(C=O)C=C(C=C1[N+]([O-])=O)[N+]([O-])=O
4-Fluoro-2,6-dinitrophenol, 98%
CAS: 364-32-9 Molecular Formula: C6H3FN2O5 Molecular Weight (g/mol): 202.10 MDL Number: MFCD00179333 InChI Key: MDOWEUXXLVBZIU-UHFFFAOYSA-N Synonym: 4-fluoro-2,6-dinitrophenol,2,6-dinitro-4-fluorophenol,phenol, 4-fluoro-2,6-dinitro,acmc-20ao7v,phenol, 2,6-dinitro-4-fluoro-, PubChem CID: 94951 IUPAC Name: 4-fluoro-2,6-dinitrophenol SMILES: OC1=C(C=C(F)C=C1[N+]([O-])=O)[N+]([O-])=O
3,5-Dinitrosalicylic acid, 98%
CAS: 609-99-4 Molecular Formula: C7H4N2O7 Molecular Weight (g/mol): 228.12 MDL Number: MFCD00007104 InChI Key: LWFUFLREGJMOIZ-UHFFFAOYSA-N Synonym: 3,5-dinitrosalicylic acid,2-hydroxy-3,5-dinitrobenzoic acid,3,5-dinitro-2-hydroxybenzoic acid,3,5-dinitrosalicylate,benzoic acid, 2-hydroxy-3,5-dinitro,salicylic acid, 3,5-dinitro,dnsa,o-dncp,o-dinitrocarboxylphenol,3,5-dinitro-2-salicylic acid PubChem CID: 11873 ChEBI: CHEBI:53648 SMILES: C1=C(C=C(C(=C1[N+](=O)[O-])O)C(=O)O)[N+](=O)[O-]
4-Hydroxy-3,5-dinitrobenzoic acid, 98+%
CAS: 1019-52-9 Molecular Formula: C7H4N2O7 Molecular Weight (g/mol): 228.12 MDL Number: MFCD00017000 InChI Key: GBSWIDSKAJFWMF-UHFFFAOYSA-N Synonym: 3,5-dinitro-4-hydroxybenzoic acid,acmc-20anc3,4-hydroxy-3,5-dinitro-benzoic acid,#,benzoic acid,4-hydroxy-3,5-dinitro,4-hydroxy-3,5-dinitrobenzoic acid, 98+% PubChem CID: 70552 IUPAC Name: 4-hydroxy-3,5-dinitrobenzoic acid SMILES: OC(=O)C1=CC(=C(O)C(=C1)[N+]([O-])=O)[N+]([O-])=O
3,5-Dinitrosalicylic acid, 97+%
CAS: 609-99-4 Molecular Formula: C7H4N2O7 Molecular Weight (g/mol): 228.116 MDL Number: MFCD00007104 InChI Key: LWFUFLREGJMOIZ-UHFFFAOYSA-N Synonym: 3,5-dinitrosalicylic acid,2-hydroxy-3,5-dinitrobenzoic acid,3,5-dinitro-2-hydroxybenzoic acid,3,5-dinitrosalicylate,benzoic acid, 2-hydroxy-3,5-dinitro,salicylic acid, 3,5-dinitro,dnsa,o-dncp,o-dinitrocarboxylphenol,3,5-dinitro-2-salicylic acid PubChem CID: 11873 ChEBI: CHEBI:53648 SMILES: C1=C(C=C(C(=C1[N+](=O)[O-])O)C(=O)O)[N+](=O)[O-]
2,6-Dinitro-4-(trifluoromethyl)phenol 97.0+%, TCI America™
CAS: 393-77-1 Molecular Formula: C7H3F3N2O5 Molecular Weight (g/mol): 252.105 MDL Number: MFCD00194260 InChI Key: FXZGYEWQIGIFMC-UHFFFAOYSA-N Synonym: 4-Hydroxy-3,5-dinitrobenzotrifluoride, alpha,alpha,alpha-Trifluoro-2,6-dinitro-p-cresol PubChem CID: 164591 IUPAC Name: 2,6-dinitro-4-(trifluoromethyl)phenol SMILES: C1=C(C=C(C(=C1[N+](=O)[O-])O)[N+](=O)[O-])C(F)(F)F
Medchemexpress LLC FHD-609 | 2676211-64-4 | C47H56N8O6 | 1 G
FHD-609 is a PROTAC degrader and inhibitor of BRD9 (Bromodomain-containing protein 9). It targets ncBAF and can be used for research on a wide range of cancers that contain a mutation in a BAF complex subunit. When combined with Telomelysin or INO5401, FHD-609 may have a role in adrenocortical carcinoma (ACC) treatment.
- PROTAC degrader and inhibitor of BRD9 (Bromodomain-containing protein 9).
- Targets ncBAF.
- Applicable for research into cancers with a mutation in a BAF complex subunit.
- Potential for adrenocortical carcinoma (ACC) treatment in combination with Telomelysin or INO5401.
- Purity: 98.95%.
- Molecular weight: 829.00.
- Formula: C47H56N8O6.
- Appearance: Solid, white to off-white.
Medchemexpress LLC STO-609 | 52029-86-4 | 98.2% | 314.29 | 1 ML
STO-609 is a selective and cell-permeable inhibitor of Ca2+/calmodulin-dependent protein kinase kinase (CaM-KK), exhibiting Ki values of 80 and 15 ng/mL for recombinant CaM-KKα and CaM-KKβ, respectively. It inhibits AMP-activated protein kinase kinase (AMPKK) activity in HeLa cell lysates (IC50 ~0.02 g/ml) and is highly selective for CaM-KK, with no significant effect on downstream CaM-KI and -IV. It also inhibits both constitutively active and wild-type CaM-KKα, and suppresses Ca2+-induced activation of CaM-KIV. The inhibition mechanism is ATP-competitive.
- Selective and cell-permeable CaM-KK inhibitor.
- Inhibits AMPKK activity.
- High selectivity for CaM-KK.
- Suppresses Ca2+-induced activation of CaM-KIV.
- ATP-competitive inhibition mechanism.
- 1
- 2